Ropivacaine
Surgical anesthesia and postoperative acute pain management (epidural, nerve block)
- CAS No.
- 84057-95-4
- Indication Class
- Anesthesia / Analgesia
- Patent Expiry
- Off-patent · 2010
- Therapeutic Area
- Anesthesia / Analgesia
- Target / Mechanism
- SCN1A·SCN5A·SCN4A·SCN7A·SCN2A·+more
- Labeled Purity
- 98%+
- Registration Readiness
- GMP/DMF
- Commercialization Tier
- API (Commercialized)
- Linked Intermediates
- Confirm per inquiry
- Patent Scope
- Compound patent long expired; mature multi-source generic supply
Key Intermediates for This API
Order: listed intermediates that accept enquiries first; fragments shared across several APIs rank higherNo intermediate entries are on file for this API yet. You can still enquire by CAS number — we will route it to the supply side for manual sourcing.
Listing Logic · Why It's Worth Listing
A long-acting local anesthetic for enhanced-recovery (ERAS) pathways with lower cardiotoxicity than bupivacaine; growth in day-surgery directly lifts volume.
Anesthesia / Analgesia · Marketed; available for immediate sourcing
GMP/DMF-ready; supports regulatory filing and audit in target markets
Intermediates confirmed per inquiry
Product Description
Ropivacaine is a modern medication primarily used for pain management during and after surgeries. It provides effective, long-lasting pain relief and is known for its targeted action and favorable safety profile.
Supply source: Unibest · Ropivacaine, sourced, vetted and delivered by Unibest. Therapeutic area, indication and listing rationale are qualitative summaries based on public drug knowledge for business reference; actual registration availability and quality specifications are subject to DMF/GMP documentation and the technical agreement confirmed at order.